MOUNTAIN VIEW, Calif., Oct. 16, 2014 /PRNewswire/ -- Frost & Sullivan has recognized CyVek, Inc. for its commitment to creativity, solving unmet marketplace needs, and developing highly innovative immunoassay technology. The 2014 North American Immunoassay Technology Innovation Leadership Award is given to companies and products that deliver process-changing technologies that save time and improve workflows, while providing high-quality data and increasing efficiency.
CyVek’s flagship product, the CyPlex System, transforms immunoassay testing by delivering an advanced, fully automated, multi-analyte bench top immunoassay system that integrates a microfluidic cartridge with a state-of-the-art analyzer.
“The immunoassay analysis market has existed for some 50 years, with the single-plex ELISA assay as the oldest technology still in regular use by research and diagnostic laboratories alike, and the market remains relatively fragmented due to unmet needs of this system,” says Frost & Sullivan Senior Industry Analyst Christi Bird. “The CyPlex workflow almost entirely eliminates the shortcomings of current technologies, combining the advantages of single-plex and multi-plex in one system. It has the potential to drastically improve the landscape of immunoassay analysis procedures, and we are excited to award this distinction to CyVek.”
“This award means a great deal to us,” says Per Hellsund, CyVek’s president and CEO. “CyPlex’s ability to provide sample-to-answer test results with precision and accuracy in a sealed disposable device makes it broadly applicable across numerous sectors, including clinical applications and routine life sciences research. We are honored to be recognized for this innovation and hope to continue pushing the boundaries of multiplexing.”
The 2014 North American Immunoassay Technology Innovation Leadership Award is determined by Frost & Sullivan’s 360-degree research methodology, and represents a holistic view of industry challenges, trends, and issues.
About CyVek: CyVek is a privately funded biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology, CyPlex, for performing multi-analyte immunoassays. For more information about CyVek, please call 203-679-0395 or visit us on the Web at: www.cyplexsystems.com.
About Frost & Sullivan: Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best-practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
SOURCE CyVek, Inc.
Help employers find you! Check out all the jobs and post your resume.
